Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms, Male

Explore clinical trials studying Breast Neoplasms, Male. Study availability and eligibility vary by location and protocol.

213 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms, Male trial results

Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +5 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Western Reg MC-COH Phoenix Goodyear, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 228 locations
View Trial Details
Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

NCT06492616

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
View all 562 locations
View Trial Details
Recruiting

ETHAN - ET for Male BC

NCT05501704

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Recruiting

MALE Mamm Organoids

NCT06786663

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +4 more
Locations
  • IRCCS National Cancer Institute "Regina Elena" Rome, Italy
View Trial Details
Active, not recruiting

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

NCT03384914

Conditions
Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, +16 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory - Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana University - Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, not recruiting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

NCT01674140

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1459 locations
View Trial Details

Related conditions